SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000902664-23-000542
Filing Date
2023-01-23
Accepted
2023-01-23 16:30:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 ACORDA THERAPEUTICS, INC. p23-0335sc13da.htm SC 13D/A 115051
  Complete submission text file 0000902664-23-000542.txt   116621
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Subject) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81801 | Film No.: 23544804
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 520 MADISON AVENUE 30TH FLOOR NEW YORK NY 10022
Business Address 520 MADISON AVENUE 30TH FLOOR NEW YORK NY 10022 212-446-4000
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by) CIK: 0001595082 (see all company filings)

IRS No.: 133863161 | State of Incorp.: DE
Type: SC 13D/A